Management of drug-drug interactions on inpatient at No1 National Psychiatric Hospital

  • Nguyen Thanh Hai Hanoi University of Pharmacy
  • Duong Thi Van Ha Noi University of Pharmacy
  • Nguyen Thanh Long Hanoi University of Pharmacy
  • Nguyen Thi Thanh Tuyen National Psychatric Hospital
  • Pham Van Huy 108 Military Central Hospital

Main Article Content

Keywords

National Psychiatric Hospital No1, clinical pharmacy, drug - drug interactions

Abstract

Objective: To analyze the effectiveness of pharmacists' intervention in the management of drug-drug interactions in inpatients at the No1 National Psychiatric Hospital. Subject and method: Cross-sectional descriptive study. Result: Among 382 inpatients treated at the hospital from March 1, 2021 to March 31, 2021, 161 drug - drug interactions (16 pairs of drug - drug interactions) were detected on 127 patients. The detected drug-drug interactions were all at a serious level, in which drug interactions by pharmacodynamic mechanism accounted for 56.5%. The 3 most common drug interactions with frequency in patients were: Diazepam-olanzapine (6.0%), clozapin-risperidone (5.5%), clozapin-haloperidol (4.5%). All 161 drug interactions detected were discussed with the treating physician, of which 80.1% of consultations were approved by the physician, 18.0% of the physician partially approved and 1.9% of the physician did not agree with the advice of the pharmacist. Recorded 29.5% of drug interactions were managed and adjusted through additional monitoring of the electrocardiogram, drug discontinuation, drug substitution, and drug dose adjustment. Conclusion: Analyzed the effectiveness of clinical pharmacology activities in the management of adverse drug interactions in inpatients at the National Psychiatric Hospital No1.

Article Details

References

1. Alicia Gunterus, Shruti Lopchuk et al (2016) Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital. Ment Health Clin 6(5): 242-247.
2. João Paulo Vilela Rodrigues, Fabiana Angelo Marques et al (2019) Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. Clinical Trial PLoS One, 14(1): e0210779
3. Maria Conchita Ocana-Zurita, Isela E. Juarez-Rojop (2016) Potential drug-drug interaction in Mexican patients with schizophrenia. Expert Opinion on Drug Metabolism & Toxicology 12(4): 249-253.
4. Chadwick B, Waller D et al (2005) Potentially hazardous drug interactions with psychotropics. Advances in Psychiatric Treatment 11: 440-449.
5. Egger SS, Drewe J et al (2003) Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58(11): 773-778.
6. Hansten PD, Horn JR (2011) Drug interactions: analysis and management lippincott williams and wilkin.
7. Mezgebe Haftay Berhane, Seid Kalid %J J. Sci. Innov. Res (2015) Prevalence of potenial drug-drug interactions among psychitric patients in Ayder referral hospital, Mekelle, Tigray, Ethiopia. 4: 71-75.
8. Thomson Daniel, Berk Michael et al (2015) Tobacco use in bipolar disorder. Clinical psychopharmacology and neuroscience: The official scientific journal of the Korean College of Neuropsychopharmacology 13(1): 1-11.
9. The Government of Viet Nam. Decree No. 131/2020/NĐ-CP (2020) Regulation on clinical pharmacy organization and activities at clinical settings.